IN2014MN00843A - - Google Patents

Info

Publication number
IN2014MN00843A
IN2014MN00843A IN843MUN2014A IN2014MN00843A IN 2014MN00843 A IN2014MN00843 A IN 2014MN00843A IN 843MUN2014 A IN843MUN2014 A IN 843MUN2014A IN 2014MN00843 A IN2014MN00843 A IN 2014MN00843A
Authority
IN
India
Prior art keywords
calcium carbonate
natural
synthetic
surface reacted
core
Prior art date
Application number
Other languages
English (en)
Inventor
Patrick Schwarzentruber
Maiuta Nicola Di
Joachim Schoelkopf
Catherine Jean Ridgway
Patrick A C Gane
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47143128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014MN00843(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP11188597.6A external-priority patent/EP2591772B1/fr
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of IN2014MN00843A publication Critical patent/IN2014MN00843A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28Microcapsules or nanocapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
IN843MUN2014 2011-11-10 2012-11-08 IN2014MN00843A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11188597.6A EP2591772B1 (fr) 2011-11-10 2011-11-10 Nouveaux supports revêtus d'agent actif à libération contrôlée
US201161559253P 2011-11-14 2011-11-14
PCT/EP2012/072161 WO2013068478A1 (fr) 2011-11-10 2012-11-08 Nouveaux supports d'agent actif à libération contrôlée, à enrobage

Publications (1)

Publication Number Publication Date
IN2014MN00843A true IN2014MN00843A (fr) 2015-07-03

Family

ID=47143128

Family Applications (1)

Application Number Title Priority Date Filing Date
IN843MUN2014 IN2014MN00843A (fr) 2011-11-10 2012-11-08

Country Status (24)

Country Link
US (1) US9579291B2 (fr)
EP (1) EP2747752B1 (fr)
KR (1) KR101612655B1 (fr)
CN (1) CN103957893B (fr)
AU (1) AU2012334082B2 (fr)
BR (1) BR112014011310B1 (fr)
CA (1) CA2851069C (fr)
CL (1) CL2014001172A1 (fr)
CO (1) CO6940430A2 (fr)
DK (1) DK2747752T3 (fr)
ES (1) ES2553091T3 (fr)
IL (1) IL231959A0 (fr)
IN (1) IN2014MN00843A (fr)
MX (1) MX346884B (fr)
MY (1) MY168425A (fr)
PL (1) PL2747752T3 (fr)
PT (1) PT2747752E (fr)
RU (2) RU2665382C1 (fr)
SG (1) SG11201401350WA (fr)
SI (1) SI2747752T1 (fr)
SM (1) SMT201600010B (fr)
TW (1) TWI625129B (fr)
WO (1) WO2013068478A1 (fr)
ZA (1) ZA201403611B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2719376B1 (fr) 2012-10-12 2015-03-04 Omya International AG Formulation de médicament à rétention gastrique et systèmes d'administration et leur procédé de préparation à l'aide de carbonate de calcium fonctionnalisé
BR112015019387A2 (pt) * 2013-02-15 2017-07-18 Wellmark Int alimentação mineral - através de formulação
ES2690413T3 (es) * 2015-06-10 2018-11-20 Omya International Ag Uso de carbonato cálcico tratado mediante reacción superficial como agente antibloqueo
EP3176222A1 (fr) * 2015-12-01 2017-06-07 Omya International AG Procédé de production de granules comprenant du carbonate de calcium traité par réaction en surface
EP3426706A1 (fr) 2016-03-08 2019-01-16 Living Proof, Inc. Compositions cosmétiques longue durée
EP3275947A1 (fr) * 2016-07-25 2018-01-31 Omya International AG Carbonate de calcium traité par réaction en surface avec des cations fonctionnels
EP3400810A1 (fr) 2017-05-11 2018-11-14 Omya International AG Carbonate de calcium traité par réaction en surface dans un aliment
CN107258776A (zh) * 2017-06-29 2017-10-20 山东大农药业有限公司 一种缓释农药颗粒剂及其制备方法
BR112020004127A2 (pt) 2017-09-13 2020-09-01 Living Proof, Inc. composições protetoras de cor
BR112020004215A2 (pt) 2017-09-13 2020-09-01 Living Proof, Inc. composições cosméticas de longa duração
EP3694491A1 (fr) 2017-10-10 2020-08-19 Capsugel Belgium NV Compositions multiparticulaires gélifiantes
EP3520798A1 (fr) * 2018-01-31 2019-08-07 Omya International AG Utilisation de carbonate de calcium fonctionnalisé en tant qu'ingrédient actif
US11896685B2 (en) 2018-10-31 2024-02-13 Amorepacific Corporation Core-shell network structure comprising biopolymer and composition comprising same
KR20200049662A (ko) * 2018-10-31 2020-05-08 (주)아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
US20220105047A1 (en) * 2019-01-16 2022-04-07 Research Cooperation Foundation Of Yeungnam University Microcapsule composition using alginate gel, and method for producing same
KR20210069344A (ko) 2019-12-03 2021-06-11 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
CN111436426B (zh) * 2020-05-11 2022-04-08 北京首创股份有限公司 供水管道输水用二次加氯胶囊及其制备方法
AR123009A1 (es) 2020-07-20 2022-10-19 Omya Int Ag Agente estabilizante para composición probiótica

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223896A1 (de) 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US4657784A (en) 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1891937A1 (fr) 2006-08-25 2008-02-27 Novartis AG Formulations galéniques de l'aliskiren
PT1974807E (pt) * 2007-03-21 2010-05-10 Omya Development Ag Processo para a remoção de compostos desreguladores endócrinos
EP2070991B1 (fr) 2007-12-12 2010-09-08 Omya Development AG Procédé de fabrication de carbonate de calcium précipité à réaction en surface
EP2168572A1 (fr) * 2008-09-30 2010-03-31 Omya Development Ag Nouveau support d'agent actif à libération contrôlée
PL2421508T3 (pl) 2009-04-24 2017-06-30 Omya International Ag Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych
PT2264109E (pt) 2009-06-15 2012-05-09 Omya Development Ag Processo de preparação de carbonato de cálcio com superfície tratada por reacção e sua utilização
DK2264108T3 (da) 2009-06-15 2012-05-29 Omya Development Ag Fremgangsmåde til fremstilling af et calciumcarbonat, der har reageret på overfladen, under anvendelse af en svag syre

Also Published As

Publication number Publication date
KR20140091054A (ko) 2014-07-18
ES2553091T3 (es) 2015-12-04
BR112014011310B1 (pt) 2022-04-12
TWI625129B (zh) 2018-06-01
PT2747752E (pt) 2016-02-08
CN103957893A (zh) 2014-07-30
CA2851069C (fr) 2016-05-31
SI2747752T1 (sl) 2015-12-31
CN103957893B (zh) 2017-08-15
BR112014011310A2 (pt) 2017-05-09
RU2018123688A3 (fr) 2022-01-24
WO2013068478A1 (fr) 2013-05-16
RU2018123688A (ru) 2019-03-07
AU2012334082A1 (en) 2014-04-24
EP2747752A1 (fr) 2014-07-02
ZA201403611B (en) 2015-07-29
MX2014005466A (es) 2014-08-22
SG11201401350WA (en) 2014-05-29
US20140248340A1 (en) 2014-09-04
CL2014001172A1 (es) 2014-09-12
TW201328709A (zh) 2013-07-16
NZ623515A (en) 2016-09-30
US9579291B2 (en) 2017-02-28
RU2665382C1 (ru) 2018-08-29
DK2747752T3 (en) 2016-01-18
CA2851069A1 (fr) 2013-05-16
MX346884B (es) 2017-04-05
SMT201600010B (it) 2016-02-25
IL231959A0 (en) 2014-05-28
KR101612655B1 (ko) 2016-04-14
PL2747752T3 (pl) 2016-04-29
AU2012334082B2 (en) 2015-10-29
MY168425A (en) 2018-11-09
CO6940430A2 (es) 2014-05-09
EP2747752B1 (fr) 2015-10-07

Similar Documents

Publication Publication Date Title
IN2014MN00843A (fr)
TN2014000141A1 (en) New coated controlled release active agent carriers
UY32151A (es) Nuevo portador de agentes activos liberados de forma controlada
MY183859A (en) Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
TN2014000133A1 (en) Environmentally friendly tanning composition
NZ705985A (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
TN2011000370A1 (en) Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof
EP2582815A4 (fr) Procédé de production d'acides aminés de la famille de l'aspartate au moyen de microorganismes
PL2265709T3 (pl) Mikroorganizmy do produkcji kwasu adypinowego i innych związków
MY165754A (en) Catalyst for producing acrylic acids and acrylates
EP2636451A4 (fr) Catalyseur oxyde, procédé de fabrication d'un catalyseur oxyde, procédé de fabrication d'acide insaturé et procédé de fabrication de nitrile insaturé
SG191068A1 (en) New form of administration of enkephalinase inhibitor
MX2013009805A (es) Preparación de sales de guanidina bicíclica en un medio acuoso.
IL213472A0 (en) Process for producing optically active carboxylic acid and uses of the same
EP2653221A4 (fr) Appareil et procédé de production d'un catalyseur, et procédé de production d'acide insaturé ou de nitrile insaturé
PL2588439T3 (pl) Sposób wytwarzania kwasu mrówkowego drogą reakcji ditlenku węgla z wodorem
GEP20125680B (en) Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydra-zinium) ropionate esters and their use for 3-(2,2,2-rimethyl- hydrazinium) propionate dihydrate preparation
MX2012002507A (es) Sales de percarbonato expandido, metodos de produccion y usos de la mismas.
ZA201208378B (en) Process for the production of ferrous sulphate monohydrate
IN2014MN00358A (fr)
ZA201501280B (en) Use of substituted 2,3-dihydro-1-benzofuran-4-carboxylic acids or salts thereof as active substances against abiotic plant stress
EP2589621A4 (fr) Procédé de décomposition de poly(acide lactique)
EP2522737A4 (fr) Procédé de production de l-amino-acide
UA61374U (ru) Способ стабилизаци полугидрата сульфата кальция
UA72437U (ru) Субстрат для выращивания растений